Home/Filings/4/0001248146-04-000001
4//SEC Filing

KOS PHARMACEUTICALS INC 4

Accession 0001248146-04-000001

CIK 0001018952operating

Filed

Feb 8, 7:00 PM ET

Accepted

Feb 9, 4:06 PM ET

Size

15.0 KB

Accession

0001248146-04-000001

Insider Transaction Report

Form 4
Period: 2003-12-31
JAHARIS MARY
10% Owner
Transactions
  • Conversion

    Common Stock, $.01 par value

    2003-12-31$4.91/sh+5,091,650$25,000,0025,111,651 total(indirect: By Spouse)
  • Conversion

    $25 Million Convertible Note

    2003-12-31(indirect: By Wilson Point Holdings, LP)
    Exercise: $4.91Exp: 2003-12-31Common Stock (3,841,650 underlying)
  • Conversion

    Common Stock, $.01 par value

    2003-12-31$4.91/sh+3,841,650$18,862,5023,841,650 total(indirect: By Wilson Point Holdings, LP)
Holdings
  • Common Stock, $.01 par value

    44,227
  • Common Stock, $.01 par value

    (indirect: See footnote 5.)
    960,069
  • Common Stock, $.01 par value

    (indirect: See footnote 4.)
    7,610,000
Footnotes (6)
  • [F1]These shares are owned directly by Wilson Point Holdings, LP ("Wilson Point"), a ten percent owner of the Issuer. Mary Jaharis, as the sole manager of Cubs Management, LLC ("Cubs Management"), a Delaware limited liability company that is the sole general partner of Wilson Point, has sole voting and dispositive power with respect to these shares. Mary Jaharis disclaims beneficial ownership of all securities held or beneficially owned, directly or indirectly, by Cubs Management and Wilson Point, except to the extent of her pecuinary interest therein, and this report should not be deemed an admission that Mary Jaharis is the beneficial owner of all such securities for purposes of Section 16 or for any other purpose.
  • [F2]One share held jointly by Mary Jaharis with Mary Jaharis' spouse.
  • [F3]Mary Jaharis disclaims beneficial ownership of all securities held or beneficially owned, directly or indirectly, by Mary Jaharis' spouse, and this report should not be deemed an admission that Mary Jaharis is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
  • [F4]Mary Jaharis' spouse is the indirect controlling shareholder of the corporation that owns such securities.
  • [F5]Mary Jaharis' spouse is the controlling shareholder of the corporation that owns such securities.
  • [F6]The convertible note is immediately exercisable.

Issuer

KOS PHARMACEUTICALS INC

CIK 0001018952

Entity typeoperating
IncorporatedFL

Related Parties

1
  • filerCIK 0001018952

Filing Metadata

Form type
4
Filed
Feb 8, 7:00 PM ET
Accepted
Feb 9, 4:06 PM ET
Size
15.0 KB